Clinical Trials Logo

Clinical Trial Summary

Increases in the aging population has resulted in increased demand for glaucoma services. Glaucoma is a disease that if untreated, can lead to blindness. This increase and need for long term treatment with monitoring have resulted in a significant demand in the hospital eye service (HES). Many departments are now facing a considerable backlog of outpatient appointments and it's essential that these appointments are reserved for patients who are at risk of glaucoma blindness. Primary angle closure (PAC) glaucoma is a type of glaucoma, where the drainage route for the fluid inside the eye (known as the angle) is narrowed or blocked. It has been recently identified that approximately half of patients referred into the HES for a suspect narrow angle for further investigation are healthy and are immediately discharged. The exact reasons for these findings are unknown. This project will investigate clinical decisions by community optometrists who account for the majority of PAC referrals into the HES, as well as assessing their ability to evaluate those at risk of PAC. This project will also examine whether clinical agreement could be improved by providing an educational package. A clinical image database of angles will be acquired from glaucoma patients attending Moorfields Eye Hospital. A learning package discussing angle closure referral will also be developed. Community optometrists will be invited to complete a questionnaire on their clinical decision making. This will be followed by the vignette assessment, learning package and re-assessment. If this educational package and/or any other identifiers are found to improve agreement levels, this could reduce the number of referrals and enable community monitoring of those at low risk of developing PAC glaucoma in their lifetime.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05543889
Study type Observational
Source Moorfields Eye Hospital NHS Foundation Trust
Contact
Status Active, not recruiting
Phase
Start date December 7, 2022
Completion date March 7, 2024

See also
  Status Clinical Trial Phase
Completed NCT00350428 - Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure N/A
Recruiting NCT03626675 - Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy N/A
Completed NCT01895686 - Comparison of Gonioscopy With Cirrus and Visante
Completed NCT02474238 - Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy N/A
Completed NCT02199158 - Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies N/A
Completed NCT00524758 - Oculusgen (Ologen) Glaucoma MMC Control in Estonia Phase 3
Active, not recruiting NCT04242108 - Diagnostic Performance of Deep Learning for Angle Closure
Completed NCT04476810 - Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade N/A
Active, not recruiting NCT05576493 - Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma N/A